rediff.com
e.g. Tata motors, Reliance MF, 500570
Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Quarterly results in brief
(Rs crore)
Dec' 24 Sep' 24 Jun' 24 Mar' 24 Dec' 23
Sales 1,101.92 1,128.91 1,077.27 926.07 1,085.29
Operating profit 336.33 302.91 315.83 227.15 327.18
Interest 2.48 0.73 0.72 1.42 2.36
Gross profit 367.08 342.52 343.48 259.41 338.55
EPS (Rs) 20.14 18.75 18.83 12.88 17.42
Quarterly  results in details
Dec' 24 Sep' 24 Jun' 24 Mar' 24 Dec' 23
Other income 33.23 40.34 28.37 33.68 13.73
Stock adjustment 4.00 17.60 -25.08 -59.42 31.01
Raw material 210.14 207.09 238.41 259.03 239.04
Power and fuel - - - - -
Employee expenses 245.71 241.65 265.68 215.97 216.41
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 305.74 359.66 282.43 283.34 271.65
Provisions made - - - - -
Depreciation 34.93 33.32 32.92 33.47 33.41
Taxation 79.70 74.22 74.53 63.25 84.99
Net profit / loss 252.45 234.98 236.03 162.69 220.15
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 25.07 25.07 25.07 25.27 25.27
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 30.52 26.83 29.32 24.53 30.15
GPM (%) 32.34 29.29 31.07 27.03 30.80
NPM (%) 22.24 20.10 21.35 16.95 20.03
Close
Add Ajanta Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Ajanta Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close